142 related articles for article (PubMed ID: 32893845)
1. Reduced Caudal Type Homeobox 2 (CDX2) Promoter Methylation Is Associated with Curcumin's Suppressive Effects on Epithelial-Mesenchymal Transition in Colorectal Cancer Cells.
Chen T; Yang C; Xi Z; Chen F; Li H
Med Sci Monit; 2020 Sep; 26():e926443. PubMed ID: 32893845
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Inhibits Cell Viability and Increases Apoptosis of SW620 Human Colon Adenocarcinoma Cells via the Caudal Type Homeobox-2 (CDX2)/Wnt/β-Catenin Pathway.
Jiang X; Li S; Qiu X; Cong J; Zhou J; Miu W
Med Sci Monit; 2019 Oct; 25():7451-7458. PubMed ID: 31584928
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
4. CDX2 as a Predictive Biomarker Involved in Immunotherapy Response Suppresses Metastasis through EMT in Colorectal Cancer.
Wang YS; Kou Y; Zhu RT; Han BW; Li CH; Wang HJ; Wu HB; Xia TM; Che XM
Dis Markers; 2022; 2022():9025668. PubMed ID: 36277982
[TBL] [Abstract][Full Text] [Related]
5. CDX2 inhibits epithelial-mesenchymal transition in colorectal cancer by modulation of Snail expression and β-catenin stabilisation via transactivation of PTEN expression.
Yu J; Li S; Xu Z; Guo J; Li X; Wu Y; Zheng J; Sun X
Br J Cancer; 2021 Jan; 124(1):270-280. PubMed ID: 33239678
[TBL] [Abstract][Full Text] [Related]
6. Methylation of CDX2 as a Predictor in Poor Clinical Outcome of Patients with Colorectal Cancer.
Jiang G; Luo C; Sun M; Zhao Z; Li W; Chen K; Fan T
Genet Test Mol Biomarkers; 2016 Nov; 20(11):710-714. PubMed ID: 27754705
[TBL] [Abstract][Full Text] [Related]
7. Promoter methylation downregulates CDX2 expression in colorectal carcinomas.
Kawai H; Tomii K; Toyooka S; Yano M; Murakami M; Tsukuda K; Shimizu N
Oncol Rep; 2005 Mar; 13(3):547-51. PubMed ID: 15706431
[TBL] [Abstract][Full Text] [Related]
8. Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line.
Yen HY; Tsao CW; Lin YW; Kuo CC; Tsao CH; Liu CY
Sci Rep; 2019 Nov; 9(1):17267. PubMed ID: 31754130
[TBL] [Abstract][Full Text] [Related]
9. Caudal homeobox protein Cdx-2 cooperates with Wnt pathway to regulate claudin-1 expression in colon cancer cells.
Bhat AA; Sharma A; Pope J; Krishnan M; Washington MK; Singh AB; Dhawan P
PLoS One; 2012; 7(6):e37174. PubMed ID: 22719836
[TBL] [Abstract][Full Text] [Related]
10. The correlation of epithelial-mesenchymal transition-related gene expression and the clinicopathologic features of colorectal cancer patients in Taiwan.
Dai YC; Fang CY; Yang HY; Jian YJ; Wang SC; Liu YW
PLoS One; 2021; 16(7):e0254000. PubMed ID: 34214117
[TBL] [Abstract][Full Text] [Related]
11. CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway.
Graule J; Uth K; Fischer E; Centeno I; Galván JA; Eichmann M; Rau TT; Langer R; Dawson H; Nitsche U; Traeger P; Berger MD; Schnüriger B; Hädrich M; Studer P; Inderbitzin D; Lugli A; Tschan MP; Zlobec I
Clin Epigenetics; 2018 Sep; 10(1):120. PubMed ID: 30257705
[TBL] [Abstract][Full Text] [Related]
12. Esculetin enhances the inhibitory effect of 5-Fluorouracil on the proliferation, migration and epithelial-mesenchymal transition of colorectal cancer.
Yan L; Yu HH; Liu YS; Wang YS; Zhao WH
Cancer Biomark; 2019; 24(2):231-240. PubMed ID: 30689555
[TBL] [Abstract][Full Text] [Related]
13. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
14. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia.
Niu H; Jia Y; Li T; Su B
Dig Dis Sci; 2017 Jan; 62(1):124-132. PubMed ID: 27913994
[TBL] [Abstract][Full Text] [Related]
15. Curcumin Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells through the Inhibition of Akt/mTOR Pathway.
Zhu FQ; Chen MJ; Zhu M; Zhao RS; Qiu W; Xu X; Liu H; Zhao HW; Yu RJ; Wu XF; Zhang K; Huang H
Biol Pharm Bull; 2017 Jan; 40(1):17-24. PubMed ID: 27829579
[TBL] [Abstract][Full Text] [Related]
16. Recombinant lentivirus with enhanced expression of caudal-related homeobox protein 2 inhibits human colorectal cancer cell proliferation in vitro.
He S; Sun XJ; Zheng JB; Qi J; Chen NZ; Wang W; Wei GB; Liu D; Yu JH; Lu SY; Wang H
Mol Med Rep; 2015 Aug; 12(2):1838-44. PubMed ID: 25847407
[TBL] [Abstract][Full Text] [Related]
17. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
18. Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial-mesenchymal transition.
Zhang C; Xu Y; Wang H; Li G; Yan H; Fei Z; Xu Y; Li W
Anticancer Drugs; 2018 Apr; 29(4):334-340. PubMed ID: 29420338
[TBL] [Abstract][Full Text] [Related]
19. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] system in the epithelial-mesenchymal transition(EMT) for colorectal cancer(CRC).
Wang Y; Wu Z; Hu L
Eur J Pharmacol; 2018 Sep; 834():45-53. PubMed ID: 30017802
[TBL] [Abstract][Full Text] [Related]
20. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]